Blood‐based transcriptional risk score for Parkinson's disease is associated with cognitive decline in Alzheimer's disease

Abstract

Background: Mixed pathology in Alzheimer's disease (AD) contributes to diverse endophenotypes and disease progression. While alpha‐synucleinopathy often co‐occurs with AD, its transcriptional risk effect on clinical outcomes is not well understood.

The paper